ImmunoCellular Therapeutics, Ltd. — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/44218d64-5133-4078-902c-ded3f50d6c56/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2017 | $0 | 2017-01-01 – 2017-12-31 | evidence 0000822411-18-000004 |
| FY 2016 | $0 | 2016-01-01 – 2016-12-31 | evidence 0001628280-17-002439 |
| FY 2015 | $0 | 2015-01-01 – 2015-12-31 | evidence 0001628280-16-013931 |
| FY 2014 | $0 | 2014-01-01 – 2014-12-31 | evidence 0001628280-16-013931 |
| FY 2013 | $300.0k | 2004-03-01 – 2014-03-31 | evidence 0001564590-14-002006 |
| FY 2012 | $300.0k | 2004-02-25 – 2013-03-31 | evidence 0000950123-13-003511 |
| FY 2011 | $300.0k | 2004-02-25 – 2012-03-31 | evidence 0001193125-12-228131 |
| FY 2010 | $0 | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-125451 |
| FY 2009 | $300.0k | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-125451 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ImmunoCellular Therapeutics, Ltd. — all facts · Net Income · Operating Income